Total Payments
$2,078
2021 Payments
$114.00
Companies
8
Transactions
41
Medicare Patients
12,351
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$2,078 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,078 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,279 | 12 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $571.68 | 17 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97.62 | 5 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $44.98 | 2 | $0 (2018) |
| Daiichi Sankyo Inc. | $28.72 | 2 | $0 (2018) |
| Medtronic Vascular, Inc. | $20.80 | 1 | $0 (2017) |
| Roche Diagnostics Corporation | $17.93 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $17.18 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $114.00 | 1 | AstraZeneca Pharmaceuticals LP ($114.00) |
| 2020 | $170.04 | 3 | AstraZeneca Pharmaceuticals LP ($120.86) |
| 2019 | $363.73 | 3 | AstraZeneca Pharmaceuticals LP ($363.73) |
| 2018 | $612.62 | 17 | AstraZeneca Pharmaceuticals LP ($374.63) |
| 2017 | $817.33 | 17 | Janssen Pharmaceuticals, Inc ($477.51) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/27/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: DIABETES | ||||||
| 02/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: DIABETES | ||||||
| 09/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $116.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $127.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2018 | Roche Diagnostics Corporation | DIS Navify Software (Device) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diagnostic Information Solutions | ||||||
| 09/19/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Anemia | ||||||
| 07/25/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Anemia | ||||||
| 07/11/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $116.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Oncology | ||||||
| 03/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/07/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| Category: Oncology | ||||||
| 02/21/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/31/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: DIABETES | ||||||
| 01/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/03/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.56 | General |
| Category: Oncology | ||||||
| 11/29/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 3,347 | 5,155 | $839,310 | $442,982 |
| 2022 | 13 | 3,266 | 4,942 | $778,752 | $420,006 |
| 2021 | 11 | 3,056 | 4,746 | $729,071 | $405,474 |
| 2020 | 15 | 2,682 | 3,986 | $613,833 | $317,862 |
Total Patients
12,351
Total Services
18,829
Medicare Billing
$1.6M
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 762 | 1,398 | $489,300 | $244,338 | 49.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 555 | 1,147 | $86,025 | $55,403 | 64.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 435 | $65,250 | $47,623 | 73.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 279 | 279 | $62,775 | $38,126 | 60.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 447 | 670 | $50,250 | $15,173 | 30.2% |
| 92625 | Evaluation of hearing ringing in ear | Office | 2023 | 176 | 192 | $18,240 | $11,515 | 63.1% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 211 | 287 | $21,525 | $11,433 | 53.1% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 209 | 210 | $17,850 | $6,876 | 38.5% |
| 92567 | Test to assess middle ear function | Office | 2023 | 185 | 292 | $11,680 | $4,281 | 36.7% |
| 92550 | Test for eardrum and muscle function | Office | 2023 | 209 | 210 | $10,290 | $4,142 | 40.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 34 | 35 | $6,125 | $4,071 | 66.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 720 | 1,266 | $443,100 | $226,734 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 325 | 522 | $78,300 | $59,751 | 76.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 505 | 1,011 | $75,825 | $49,432 | 65.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 284 | 284 | $52,540 | $27,175 | 51.7% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 386 | 564 | $42,300 | $13,630 | 32.2% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 245 | 329 | $24,675 | $12,984 | 52.6% |
| 92625 | Evaluation of hearing ringing in ear | Office | 2022 | 105 | 123 | $11,685 | $7,625 | 65.3% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 192 | 192 | $16,320 | $6,554 | 40.2% |
| 92567 | Test to assess middle ear function | Office | 2022 | 249 | 392 | $15,680 | $6,101 | 38.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 36 | 40 | $7,000 | $4,863 | 69.5% |
| 92550 | Test for eardrum and muscle function | Office | 2022 | 193 | 193 | $9,457 | $3,934 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,045 | $822.32 | 78.7% |
| 92542 | Test for abnormal eye movement using 3 positions with recording | Office | 2022 | 15 | 15 | $825.00 | $401.55 | 48.7% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 616 | 1,176 | $411,600 | $223,278 | 54.2% |
About Dr. Khrosrow Makki, MD
Dr. Khrosrow Makki, MD is a Otolaryngology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790755262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khrosrow Makki, MD has received a total of $2,078 in payments from pharmaceutical and medical device companies, with $114.00 received in 2021. These payments were reported across 41 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($2,078).
As a Medicare-enrolled provider, Makki has provided services to 12,351 Medicare beneficiaries, totaling 18,829 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Washington, DC
- Active Since 01/25/2006
- Last Updated 04/14/2014
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1790755262
Products in Payments
- FARXIGA (Drug) $1,119
- INVOKANA (Drug) $359.42
- XARELTO (Drug) $212.26
- BYDUREON (Drug) $160.24
- JARDIANCE (Drug) $40.12
- PRADAXA (Drug) $32.83
- INJECTAFER (Drug) $28.72
- TRADJENTA (Drug) $24.67
- OPDIVO (Biological) $24.56
- Reveal LINQ (Device) $20.80
- EMPLICITI (Biological) $20.42
- DIS Navify Software (Device) $17.93
- Stivarga (Drug) $17.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Washington
Michael Somenek, M.d, M.D
Otolaryngology — Payments: $745,444
Otolaryngology $745,444
Dr. Ameet Singh, M.d, M.D
Otolaryngology — Payments: $71,257
Otolaryngology $71,257
Dr. Stephen Wall, M.d.,Ph.d, M.D.,PH.D
Otolaryngology — Payments: $59,847
Otolaryngology $59,847
Dr. Michael Hoa, M.d, M.D
Otolaryngology — Payments: $59,473
Otolaryngology $59,473
Dr. Manish Khanna, M.d, M.D
Otolaryngology — Payments: $27,939
Otolaryngology $27,939
Dr. Arjun Joshi, M.d, M.D
Otolaryngology — Payments: $12,470
Otolaryngology $12,470